TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.” August 13, 2004
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012